Rocket One (RKTO) Net Shares Issued and Repurchased (2017 - 2025)
Rocket One's (RKTO) quarterly Net Shares Issued and Repurchased came in at $170000.0 in Q4 2025, down 81.58% year-over-year from $923000.0 in Q4 2024, and little changed quarter-over-quarter from $170000.0 in Q1 2025.
Powered by 
Analysis
Rocket One (RKTO) Net Shares Issued and Repurchased (2017 - 2025) Analysis & Trends
Rocket One has disclosed Net Shares Issued and Repurchased across 9 years of filings, most recently posting $170000.0 for Q4 2025.
- In Q4 2025, Net Shares Issued and Repurchased fell 81.58% year-over-year to $170000.0; the TTM figure through Dec 2025 stood at $170000.0 (down 81.58% YoY), while the FY2025 annual figure was $170000.0, down 81.58% from the prior year.
- Net Shares Issued and Repurchased came in at $170000.0 for Q4 2025 at Rocket One, roughly flat from $170000.0 in the prior quarter.
- In the past five years, Net Shares Issued and Repurchased ranged from a high of $4.5 million in Q1 2023 to a low of $2000.0 in Q1 2024.
- Average Net Shares Issued and Repurchased over 5 years is $710151.6, with a median of $170000.0 recorded in 2025.
- Year-over-year, Net Shares Issued and Repurchased plunged 99.96% in 2024 and jumped 8400.0% in 2025.
- Over 5 years, Net Shares Issued and Repurchased stood at $4000.0 in 2021, then climbed by 26.88% to $5075.0 in 2022, then jumped by 398.31% to $25289.0 in 2023, then soared by 3549.81% to $923000.0 in 2024, then sank by 81.58% to $170000.0 in 2025.
- Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $170000.0 in Q4 2025, $170000.0 in Q1 2025, and $923000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Rocket One | 13.86 Mn | 5.97 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 170,000.00 |
| Mar 31, 2025 | 170,000.00 |
| Dec 31, 2024 | 923,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 25,289.00 |
| Mar 31, 2023 | 4.46 Mn |
| Dec 31, 2022 | 5,075.00 |
| Dec 31, 2021 | 4,000.00 |
| Mar 31, 2021 | 632,000.00 |
| Dec 31, 2020 | 200,000.00 |
| Mar 31, 2020 | 95,452.00 |
| Dec 31, 2019 | 331,155.00 |
| Mar 31, 2019 | 50,000.00 |
| Dec 31, 2018 | 344,125.00 |
| Dec 31, 2017 | 647,242.00 |